Next Generation Sequencing Market Research Report: By Technology (Targeted Sequencing & Resequencing, Whole Genome Sequencing and Whole Exome Sequencing), Workflow (Pre-Sequencing, Sequencing, and Data Analysis), Application (Oncology, Clinical Investigation, Reproductive Health, Human Leukocyte Antigen Typing or Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, Consumer Genomics), End User (Hospitals & Clinics, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) – Global Forecast till 2025
According to the detailed analysis of Market Research Future (MRFR), the global Next-Generation Sequencing Market is expected to reach a remarkable valuation at a striking CAGR over the forecast period (2018–2023).
The introduction of high throughput sequencing technology has created substantial changes in the sequencing process by providing speed and lessening sequencing cost. The technology is developing at a higher rate due to its application in agricultural, clinical, and forensic fields. it has helped to identify several clinical applications such as cancer, hereditary genetic disorders, and to detect the contagious disease.
Factors such as rising technological advancements, growing awareness, increasing acquisitions, and mergers among the market players to raise revenue for new product innovations are expected to contribute substantially to the global market share. Additionally, a rise in genome mapping programs is also likely to fuel the growth of the market exponentially. However, factors such as infrastructure, skilled employees who can manage and store huge amount of data properly, along with the high cost implicated in the technology are estimated to restrain the market growth over the forecast period.
Segmental Analysis
The global market next-generation sequencing has been segmented on the basis of technology, service and product, application, and end-user.
The types of technologies adopted in the global market for next-generation sequencing are CHIP sequencing, de novo sequencing, methyl sequencing, targeted resequencing, RNA sequencing, whole-exome sequencing, and whole-genome sequencing.
The various forms of products and services offered in the market are consumables, platforms, and services for platforms, sample preparation, and sequencing services. The sample preparation is segmented into A-tailing and size selection, DNA fragmentation, end-repair, library preparation & target enrichment, and quality control.
the applications of the next-generation sequencing technology are agriculture and animal research, diagnostics, drug discovery, genetic screening, and others.
The end-users in the market are academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end-users.
Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/6354
Regional Analysis
Based on the region, the global market for the next-generation sequencing market is analyzed in North America, Latin America, Asia Pacific, Europe, and the middle east and Africa.
North America is anticipated to account for the largest market share in the next-generation sequencing market over the review period. Factors such as an increase in consumer necessities and augmented competition among market players in the region through acquisitions and mergers are likely to drive the growth of the market over the forecast period. The growth in the number of resources and initiatives implemented by the government to reduce the cancer prevalence and to advance the healthcare sector is also likely to contribute to the market.
The European region is anticipated to hold the second-largest market share owing to the presence of ground-breaking next-generation sequencing technology, a very sophisticated and educated population that is taking an interest in next-generation technology (NGS). however, the diverse rules and regulations and a fragmented market can create challenges for the market growth over the forecast period, creating a disruption in terms of growth.
The market share in Asia-Pacific is also anticipated to witness growth in the forecast period owing to the access to most favorable treatment facilities and increasing demand for advanced technologies, higher adoption rate, enhancement in disposable income, and expanding investments by pharmaceutical companies in the market over the forecast period.
The next-generation sequencing market in the Middle East and Africa is projected to account for the smallest share of the next-generation sequencing market due to a weak healthcare sector, lack of technological knowledge and skilled workforce, and poor medical facilities. The middle east is likely to contribute substantially towards the market share
Browse Complete Toc :
https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354
Key Players
Some of the key players in the global market for next-generation sequencing Agilent Technologies (US), BGI (China), Eurofins Scientific (Luxembourg).Illumina, Inc. (US), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), Pacific Biosciences of California, Inc. (US), PerkinElmer (US), QIAGEN N. V. (Germany), and Thermo Fisher Scientific, Inc. (the US).
Related Report: https://www.marketresearchfuture.com/infographics/meningitis-diagnosis-and-treatment-market
https://www.marketresearchfuture.com/infographics/medical-implants-market
https://www.marketresearchfuture.com/infographics/laparoscopy-device-market
https://www.marketresearchfuture.com/infographics/lancet-market
https://www.marketresearchfuture.com/infographics/wearable-display-device-materials-market
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid-19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.
Next Generation Sequencing Market Research Report: By Technology (Targeted Sequencing & Resequencing, Whole Genome Sequencing and Whole Exome Sequencing), Workflow (Pre-Sequencing, Sequencing, and Data Analysis), Application (Oncology, Clinical Investigation, Reproductive Health, Human Leukocyte Antigen Typing or Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, Consumer Genomics), End User (Hospitals & Clinics, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Global Forecast till 2025Global Next Generation Sequencing Market Share is expected to exhibit significant growth over the forecast period.
The NGS Market Growth is projected to register a CAGR of 18.05% over the forecast period to reach USD 20,347.45 Million by 2025.There are various diseases that have their roots in genetics such as cancer, diabetes, Alzheimer’s, arthritis, heart disease etc.
To discover viable treatment to these diseases, researchers are looking to discern how genes work.
Next generation sequencing market has been gaining impetus due to the fact that next-generation sequencing is integral to field of genomics.
The NGS technologies are implemented for several applications, including whole genome sequencing, de novo assembly sequencing, resequencing, and transcriptome sequencing at the DNA or RNA level.
The successful application of next-generation sequencing can lead to predicting of genes, protein coding regions, and pathways.Illumina, Helicos Biosciences, Thermo Fisher Scientific, Roche, Pacific Bioscience, ABI Life Technologies, and Oxford Nanopore are some of the companies that are implementing different NGS technologies which in turn will augment global next generation sequencing market which is estimated to reach a massive market valuation by 2023.Next Generation Sequencing Market Competitive Landscape:Some of the key players in the global next-generation sequencing market Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., BGI, PerkinElmer, Agilent Technologies, QIAGEN N. V., Macrogen Inc., Oxford Nanopore Technologies, Ltd., and Eurofins Scientific.
The global next generation sequencing market expected to reach US$ 25.85 billion by 2028 according to a new study by Polaris Market Research.
The report “Next Generation Sequencing (NGS) Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Discovery/Personalized Medicine, Genetic Screening, Diagnostics/Infectious Diseases, Agricultural & Animal Research); By Technology; By Product; By End-Use; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Market players are focusing on developing automated sequencers equipped with high speed and accuracy.
This has also enabled increased adoption in emerging nations.
The global next-generation sequencing market is fragmented based on application, technology, product, end-use, and region.
In terms of application, the market is segmented into drug discovery/personalized medicine, genetic screening, diagnostics/infectious diseases, agricultural & animal research, and others.
Next Generation Sequencing Market OverviewThere are various diseases that have their roots in genetics such as cancer, diabetes, Alzheimer’s, arthritis, heart disease etc.
To discover viable treatment to these diseases, researchers are looking to discern how genes work.
Next generation sequencing market has been gaining impetus due to the fact that next-generation sequencing is integral to field of genomics.
The NGS technologies are implemented for several applications, including whole genome sequencing, de novo assembly sequencing, resequencing, and transcriptome sequencing at the DNA or RNA level.
The successful application of next-generation sequencing can lead to predicting of genes, protein coding regions, and pathways.Illumina, Helicos Biosciences, Thermo Fisher Scientific, Roche, Pacific Bioscience, ABI Life Technologies, and Oxford Nanopore are some of the companies that are implementing different NGS technologies which in turn will augment global next generation sequencing market which is estimated to reach a massive market valuation by 2023.Next Generation Sequencing Market Segmentation:The next generation sequencing market has been classified by technology, service and product, application, and end-user.By technology, next generation sequencing market has been segmented as whole genome sequencing, methyl sequencing, whole exome sequencing, targeted resequencing, CHIP sequencing, RNA sequencing and de novo sequencing.By service & product, next generation sequencing market has been segmented as consumables, sample preparation, sequencing services and platforms and services for platforms.By application, NGS market has been segmented as genetic screening, drug discovery, diagnostics, agriculture and animal research and others.End-users segmentation of the next generation sequencing market includes academic institutes and research centers, pharmaceutical and biotechnology companies, hospitals and clinics, and other end-users.Next Generation Sequencing Market Regional Analysis:Owing to rising number of funds being granted for research into genomics and initiatives adopted by the government to rein in cases of genetically occurring diseases and demand to improve the healthcare sector is estimated to augment the growth of the next generation sequencing market in North America.
Increased competition among market players as well as acquisitions and mergers are expected to drive the growth of the market in the region.Next generation sequencing market in Europe is expected to hold the second largest revenue share due to the presence of some of the leading next-generation sequencing technology companies and an educated population inclined on the advancement of next-generation sequencing technology.
Market Analysis and Insights: Global Microbiome Sequencing MarketMicrobiome sequencing market is expected to rise to an estimated value of USD 3455.33 million by 2026, registering a healthy CAGR in the forecast period of 2019-2026.
This rise in market value can be attributed to the focus of various researchers on utilization of this technology in the development of personalized medicine and dietary applications.Market Definition: Global Microbiome Sequencing MarketMicrobiome sequencing is a research technology involving the study of microbes and their roles in healthcare maintenance and disease prevalence.
This is generally carried out by sampling out human skin, stool or blood.
These samples are tested in labor-intensive techniques of microbiology studies wherein they can isolate organisms in these samples with the help of phenotyping or genotypic analysis.Request Sample is Available to Know More before Investment @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-microbiome-sequencing-marketCompetitive Analysis:Global microbiome sequencing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
The report includes market shares of microbiome sequencing market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.Market DriversIncreasing adoption of genomic research methods along with widening areas of application for microbiome sequencing technology is expected to drive the growth of the marketIncreasing demands for next-generation sequencing services will also propel the growth of the marketDecreasing costs associated with NGS technology giving rise to a greater adoption rate also acts as a market driverIncreasing investment expenditure being incurred on advancing and utilization of microbiome research will boost this market growthMarket RestraintsLack of technically proficient individuals is expected to hinder the growth of the marketConcerns regarding the legal and ethical issues in concerns to genome sequencing methods; this factor is expected to restrict the growth of the marketSegmentation: Global Microbiome Sequencing MarketBy Sequencing TechnologySanger SequencingHigh-Throughput SequencingThird-Generation SequencingSequencing By Ligation (SBL)Sequencing By Synthesis (SBS)Shotgun SequencingWhole Genome SequencingTargeted Gene SequencingRNA SequencingOthersBy ComponentReagents & KitsInstrumentsBy Targeted DiseaseGastrointestinal DiseasesInfectious DiseasesCNS DiseasesOncologyOthersBy ApplicationDrug & Biomarker DiscoveryGenetic ScreeningDisease Diagnosis ResearchTherapeuticPersonalized MedicineOthersFor Further Detailed insights and ‘Any Query About this report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-microbiome-sequencing-marketKey Market Competitors:Few of the major competitors currently working in the global microbiome sequencing market are BIOLOG; Cosmosid Inc; Illumina, Inc.; Metabiomics Corp.; Oxford Nanopore Technologies; BaseClear B.V.; BGI; BioMathematica; Charles River; CoreBiome, Inc.; Clinical-Microbiomics A/S; Diversigen; Eurofins Scientific; LABCYTE INC.; Leucine Rich Bio Pvt Ltd.; Microbiome Insights; MICROBIOME THERAPEUTICS, LLC; Thermo Fisher Scientific Inc.; Molzym GmbH & Co. KG; Norgen Biotek Corp.; Phase Genomics Inc.; QIAGEN; Resphera Biosciences, LLC; Shoreline Biome; StarSEQ GmbH; Viome, Inc.; Zymo Research among others.Request for complete Toc @ https://www.databridgemarketresearch.com/toc/?dbmr=global-microbiome-sequencing-marketResearch Methodology: Global Microbiome Sequencing MarketData collection and base year analysis is done using data collection modules with large sample sizes.
Also market share analysis and key trend analysis are the major success factors in the market report.
